B-Cell CLL/lymphoma 7A (BCL7A) Peptide
BCL7A
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all BCL7A products
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- CGSEVTTPEN SSSPGMMDMH DDNSNQSSIA DASPIKQENS SNSSPAPEPN
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of BCL7 A antibody,
Alternative Names: BCL7A control peptide, BCL7A antibody Blocking Peptide, Anti-BCL7A Blocking Peptide, B-Cell Cll/Lymphoma 7A Blocking Peptide, BCL7 Blocking Peptide, BCL7A, BCLA-7, BCLA 7, BCLA-7 Blocking Peptide, BCLA 7 Blocking Peptide
-
B-Cell CLL/lymphoma 7A (BCL7A) peptide
BCL7A Reactivity: Human, Cow, Dog, Mouse, Pig, Rat Host: Synthetic BP, Imm
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
- Background
- This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.
- Molecular Weight
- 25 kDa
-
You are here:
